KLF10 mediated epigenetic dysregulation of epithelial CD40/CD154 promotes endometriosis

11Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Endometriosis is a highly prevalent, chronic, heterogeneous, fibro-inflammatory disease that remains recalcitrant to conventional therapy. We previously showed that loss of KLF11, a transcription factor implicated in uterine disease, results in progression of endometriosis. Despite extensive homology, coexpression, and human disease association, loss of the paralog Klf10 causes a unique inflammatory, cystic endometriosis phenotype in contrast to fibrotic progression seen with loss of Klf11. We identify here for the first time a novel role for KLF10 in endometriosis. In an animal endometriosis model, unlike wildtype controls, Klf10-/- animals developed cystic lesions with massive immune infiltrate and minimal peri-lesional fibrosis. The Klf10-/- disease progression phenotype also contrasted with prolific fibrosis and minimal immune cell infiltration seen in Klf11-/- animals. We further found that lesion genotype rather than that of the host determined each unique disease progression phenotype. Mechanistically, KLF10 regulated CD40/CD154- mediated immune pathways. Both inflammatory as well as fibrotic phenotypes are the commonest clinical manifestations in chronic fibro-inflammatory diseases such as endometriosis. The complementary, paralogous Klf10 and Klf11 models therefore offer novel insights into the mechanisms of inflammation and fibrosis in a disease-relevant context. Our data suggests that divergence in underlying gene dysregulation critically determines disease-phenotype predominance rather than the conventional paradigm of inflammation being precedent to fibrotic scarring. Heterogeneity in clinical progression and treatment response are thus likely from disparate gene regulation profiles. Characterization of disease phenotype-associated gene dysregulation offers novel approaches for developing targeted, individualized therapy for recurrent and recalcitrant chronic disease.

References Powered by Scopus

Endometriosis

2891Citations
N/AReaders
Get full text

CD40 and CD154 in cell-mediated immunity

1371Citations
N/AReaders
Get full text

CD40-CD40 ligand

1254Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis

39Citations
N/AReaders
Get full text

p38 Mitogen-Activated Protein Kinase is Involved in the Pathogenesis of Endometriosis by Modulating Inflammation, but not Cell Survival

29Citations
N/AReaders
Get full text

Genome-wide analysis of DNA methylation in endometriosis using Illumina Human Methylation 450 K BeadChips

29Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Delaney, A. A., Khan, Z., Zheng, Y., Correa, L. F., Zanfagnin, V., Shenoy, C. C., … Daftary, G. S. (2016). KLF10 mediated epigenetic dysregulation of epithelial CD40/CD154 promotes endometriosis. Biology of Reproduction, 95(3). https://doi.org/10.1095/biolreprod.116.140764

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

60%

Professor / Associate Prof. 4

20%

Researcher 3

15%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 7

41%

Medicine and Dentistry 5

29%

Agricultural and Biological Sciences 4

24%

Chemistry 1

6%

Save time finding and organizing research with Mendeley

Sign up for free